GlaxoSmithKline PLC has agreed to pay up to $2.2 billion to settle more than 90% of pending U.S. state court product liability cases involving Zantac. These lawsuits claim that a discontinued version of the heartburn medication contained NDMA, a probable human carcinogen, which led to cancer in numerous users.

This settlement marks a significant step in addressing the claims of individuals and families affected by Zantac-related health issues. If you believe Zantac may have impacted your health, now is the time to consult with experienced Zantac lawsuit attorneys to understand your legal options.

By submitting your cell phone number, you agree to receive marketing messages from tortadvisor.com and its partners via voice calls, AI-generated calls, text messaging, or other automated methods. For details on how we use your information, please refer to our Privacy Policy.